Login / Signup

Effects of CD34 + cell dose on engraftment and long-term outcomes after allogeneic bone marrow transplantation.

Takashi OyamaShin-Ichiro FujiwaraRyutaro TominagaDaizo YokoyamaAtsuto NoguchiShuka FurukiShunsuke KoyamaRui MurahashiHirotomo NakashimaKazuki HyodoTakashi IkedaShin-Ichiro KawaguchiYumiko TodaTakashi NagayamaKento UminoDaisuke MinakataKaoru MoritaMasahiro AshizawaChihiro YamamotoKaoru HatanoKazuya SatoIkuko OtsukiKen OhmineYoshinobu Kanda
Published in: Clinical transplantation (2024)
cell dose in addition to NCC was useful for predicting hematopoietic recovery, but seemed to have little influence on the long-term outcome in BMT.
Keyphrases
  • bone marrow
  • cell therapy
  • single cell
  • mesenchymal stem cells
  • stem cell transplantation
  • hematopoietic stem cell
  • low dose